Osteocytic Protein Expression Response to Doxercalciferol Therapy in Pediatric Dialysis Patients - Pereira, Renata C.; Jüppner, Harald; Gales, Barbara; Salusky, Isidro B.; Wesseling-Perry, Katherine (PloS one, 2015)
Keywords: Adaptor Proteins, Signal Transducing; Adolescent; Biocompatibility; Biopsy; Bone and Bones - drug effects; Bone and Bones - metabolism; Bone and Bones - pathology; Bone Density Conservation Agents - pharmacology; Bone Density Conservation Agents - therapeutic use; Bone growth; Bone Morphogenetic Proteins - genetics; Bone Morphogenetic Proteins - metabolism; Child; Chronic kidney failure; Dentin; Dialysis; Dmp1 protein; Ergocalciferols - pharmacology; Ergocalciferols - therapeutic use; Extracellular Matrix Proteins - genetics; Extracellular Matrix Proteins - metabolism; Female; Fibroblast growth factor 23; Fibroblast growth factors; Fibroblast Growth Factors - genetics; Fibroblast Growth Factors - metabolism; Fibroblasts; Fragments; Gene Expression; Genetic Markers - genetics; Growth factors; Homeostasis; Humans; Immunohistochemistry; Kidney diseases; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - therapy; Long bone; Male; Medicine; Metabolism; Mineral metabolism; Mineralization; Mutation; Osteocytes - metabolism; Osteolysis - blood; Osteolysis - drug therapy; Osteolysis - genetics; Osteolysis - metabolism; Parathyroid hormone; Parathyroid hormones; Patients; Pediatrics; Peritoneal dialysis; Phosphoproteins - genetics; Phosphoproteins - metabolism; Phosphorus; Physiological aspects; Protein expression; Proteins; Renal Dialysis - adverse effects; Rodents; SOST protein; Sterols; Therapy; Treatment Outcome; Values; Vitamin D; Los Angeles California; San Clemente California; California; United States--US; Massachusetts